278 related articles for article (PubMed ID: 32112777)
1. Expression of non-coding RNAs in hematological malignancies.
Ghafouri-Fard S; Esmaeili M; Taheri M
Eur J Pharmacol; 2020 May; 875():172976. PubMed ID: 32112777
[TBL] [Abstract][Full Text] [Related]
2. [The role of long non-coding RNAs in hematologic malignancies].
Hu WL; Gao A
Yi Chuan; 2015 Nov; 37(11):1095-104. PubMed ID: 26582523
[TBL] [Abstract][Full Text] [Related]
3. Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.
Misso G; Zarone MR; Grimaldi A; Di Martino MT; Lombardi A; Kawasaki H; Stiuso P; Tassone P; Tagliaferri P; Caraglia M
Curr Drug Targets; 2017; 18(1):35-55. PubMed ID: 27280795
[TBL] [Abstract][Full Text] [Related]
4. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
Zhang J; Liu L; Li J; Le TD
Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
[TBL] [Abstract][Full Text] [Related]
5. miR-155 as a novel clinical target for hematological malignancies.
Witten L; Slack FJ
Carcinogenesis; 2020 Mar; 41(1):2-7. PubMed ID: 31711135
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies.
Wong NK; Huang CL; Islam R; Yip SP
J Hematol Oncol; 2018 Nov; 11(1):131. PubMed ID: 30466456
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs and MYC association in hematological malignancies.
Benetatos L; Benetatou A; Vartholomatos G
Ann Hematol; 2020 Oct; 99(10):2231-2242. PubMed ID: 32621182
[TBL] [Abstract][Full Text] [Related]
8. The role of long non-coding RNAs in the pathogenesis of thyroid cancer.
Ghafouri-Fard S; Mohammad-Rahimi H; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104332. PubMed ID: 31706987
[TBL] [Abstract][Full Text] [Related]
9. Role of microRNAs in hematological malignancies.
Fatica A; Bozzoni I
Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced modifications and modulations of microRNAs and long non-coding RNAs for future therapy against Glioblastoma Multiforme.
Janaki Ramaiah M; Divyapriya K; Kartik Kumar S; Rajesh YBRD
Gene; 2020 Jan; 723():144126. PubMed ID: 31589963
[TBL] [Abstract][Full Text] [Related]
11. Non-coding RNA profile in lung cancer.
Ghafouri-Fard S; Shoorei H; Branicki W; Taheri M
Exp Mol Pathol; 2020 Jun; 114():104411. PubMed ID: 32112788
[TBL] [Abstract][Full Text] [Related]
12. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of let-7 family in the pathogenesis of hematological malignancies.
Yazarlou F; Kadkhoda S; Ghafouri-Fard S
Biomed Pharmacother; 2021 Dec; 144():112334. PubMed ID: 34656064
[TBL] [Abstract][Full Text] [Related]
15. Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.
Ghafouri-Fard S; Shoorei H; Abak A; Abbas Raza SH; Pichler M; Taheri M
Biomed Pharmacother; 2021 Feb; 134():111172. PubMed ID: 33360156
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma.
Wu Y; Qian Z
Discov Med; 2019 Sep; 28(153):129-138. PubMed ID: 31926584
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.
Ye S; Yang L; Zhao X; Song W; Wang W; Zheng S
Cell Biochem Biophys; 2014 Dec; 70(3):1849-58. PubMed ID: 25087086
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNAs: emerging regulators of normal and malignant hematopoiesis.
Qiu Y; Xu M; Huang S
Blood; 2021 Dec; 138(23):2327-2336. PubMed ID: 34482397
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
Barbarotto E; Calin GA
Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
